Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Barbosa-Matos (Braga, Portugal), C. Borges-Pereira (Braga, Portugal), S. Libório-Ramos (Braga, Portugal), M. Mazzone (Leuven, Belgium), S. Costa (Braga, Portugal). c-Met expression induction in immune cells modulates pulmonary fibrosis progression. 2583

Member's Comments

No comment yet.

Related content which might interest you: Over-expression of SIGIRR attenuates TLR 4,5,9-mediated immune responses in human airway epithelial cells Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Antifibrotics modulate B lymphocyte activation resulting in a decrease of the profibrotic milieu in patients with pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 180-189 Year: 2001 Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1137-1149 Year: 2016 ET-1 regulates pathological cell proliferation by ERK1/2 in a state of chronic inflammation Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Kaempferol-induced HO-1 expression attenuated inflammation in human pulmonary alveolar epithelial cells Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 Dual role of pulmonary T cells in fibrosis is defined by expression of integrins Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Upregulation of the production of TGF-β and IL-4 and downregulation of IL-6 by apoptotic human bronchial epithelial cells: possible role in regulation of epithelial repair following acute lung injury Source: Eur Respir J 2001; 18: Suppl. 33, 477s Year: 2001 Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 79-87 Year: 2011 Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005 The PD-1 immune checkpoint promotes lung damage in murine models of COPD-like inflammation Source: International Congress 2019 – Injury and repair: less is more Year: 2019 Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 P2X7 receptor regulates cell survival, inflammation processes and proliferation of lung carcinoma cells Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019